ACSL4 Recombinant Antbody Kit (KD-Validated)
Applications
Reactivity
| Overview | |
| Catalog # | bsm-90049r-50uL |
| Product Name | ACSL4 Recombinant Antbody Kit (KD-Validated) |
| Applications |
WB
FCM
IC
|
| Specificity | Knockdown Validated |
| Reactivity | Human, Mouse |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | A synthesized peptide derived from human ACSL4 |
| Immunogen Range | 650-691/711 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Affinity Purified |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | -20 °C |
| Target | |
| Gene ID | 2182 |
| Swiss Prot | O60488 |
| Synonyms | ACSL4; Acyl-CoA Synthetase Long Chain Family Member 4; LACS4; ACS4; FACL4; Fatty-Acid-Coenzyme A Ligase Long-Chain 4; Long-Chain Fatty-Acid-Coenzyme A Ligase 4; Long-Chain-Fatty-Acid--CoA Ligase 4; Long-Chain Acyl-CoA Synthetase 4; Lignoceroyl-CoA Synthase; Arachidonate--CoA Ligase; EC 6.2.1.3; MRX63; MRX68; Mental Retardation X-Linked 63; Mental Retardation X-Linked 68; Acyl-CoA Synthetase 4; EC 6.2.1.15; XLID63; LACS 4 |
| Background | Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution | |
| WB | 1:300-5000 |
| FCM | 1:20-100 |
| IC | 1:1000 |